TrialThe oncologist2022
Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma.
Richard F Riedel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
TrialThe oncologist2022
Richard F Riedel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.